PRESS-RELEASE ·Filed Jul 8, 2026
Press release: earnings
Actionable Insight • Neutral
Monitor the Q2 2026 earnings release on August 6 for financial performance and guidance updates.
Final — all horizons settled through T+60d
EVH ▼ -38.54% at T+60d
NEUTRAL call ✗ call lost -38.54% · α vs SPY -40.18% · entry $5.63 → $3.46
T+1d
+4.44%
call +4.44% · α +4.01%
$5.88
settled 3mo ago
T+5d
+0.71%
call +0.71% · α +0.84%
$5.67
settled 3mo ago
T+20d
-36.23%
call -36.23% · α -38.48%
$3.59
settled 8w ago
T+60d
-38.54%
call -38.54% · α -40.18%
$3.46
settled yesterday
Price Chart
Loading chart...
Executive Summary
Evolent Health announced it will release Q2 2026 financial results on August 6, 2026, before market open. No financial results or guidance were provided in this press release.
Key Facts
- Q2 2026 earnings release scheduled for August 6, 2026 before market open
Financial Impact
Not specified
Market Snapshot
Exchange
NYSE
Sector
Services-Management Services
Analyst Consensus
79% bullish (19 analysts)
Investment Themes
Services
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302820804 |
4 reports for EVH
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 6, 2026 8w ago | 8-K | $3.59 $4.26 | ▲ +18.66% | ▲ +18.06% | $3.46 (−3.62%) |
Jul 8, 2026 12w ago | Press Release | $5.63 $3.59 | ▼ −36.23% | ▼ −38.48% | $3.46 (−38.54%) |
Apr 24, 2026 23w ago | DEFA14A | $3.47 $3.83 | ▲ +10.37% | ▲ +5.42% | $3.46 (−0.29%) |
Feb 24, 2026 31w ago | 8-K | $3.14 $2.27 | ▼ −27.71% | ▼ −22.47% | $3.46 (+10.19%) |
Showing 4 of 4
US Market Status
Market Closed — Opens Mon (64h 38m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access